Evidence map›Paper›PMID 28824431›Full record

ArticleFrontiers in pharmacology2017

Dibutyltin Compounds Effects on PPARγ/RXRα Activity, Adipogenesis, and Inflammation in Mammalians Cells.

Flora A Milton, Mariella G Lacerda, Simone B P Sinoti, Pedro G Mesquita, Dileesh Prakasan, Michella S Coelho, Caroline L de Lima, Alexandre G Martini, Gabriela T Pazzine, Maria de F Borin and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 44 citations in OpenAlex.

  1. Triorganotin compounds as emerging nuclear retinoid X receptor ligands and their implications in cancer.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2026
    Review
  2. Article
  3. Article
  4. [Research Progress in Organocatalysts Used in the Synthesis of Medical Polyurethanes and Their Biotoxicity].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Obesity and endocrine-disrupting chemicals.Endocrine connections · 2021
    Review
  15. Review
  16. The new kids on the block: Emerging obesogens.Advances in pharmacology (San Diego, Calif.) · 2021
    Review
  17. Review
  18. Transgenerational effects of obesogens.Basic & clinical pharmacology & toxicology · 2019
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Flora A MiltonLaboratory of Molecular Pharmacology, Faculty of Health Science, University of BrasiliaBrasilia, Brazil.
Mariella G LacerdaLaboratory of Molecular Pharmacology, Faculty of Health Science, University of BrasiliaBrasilia, Brazil.
Simone B P SinotiLaboratory of Molecular Pharmacology, Faculty of Health Science, University of BrasiliaBrasilia, Brazil.
Pedro G MesquitaLaboratory of Molecular Pharmacology, Faculty of Health Science, University of BrasiliaBrasilia, Brazil.
Dileesh PrakasanLaboratory of Molecular Pharmacology, Faculty of Health Science, University of BrasiliaBrasilia, Brazil.
Michella S CoelhoLaboratory of Molecular Pharmacology, Faculty of Health Science, University of BrasiliaBrasilia, Brazil.
Caroline L de LimaLaboratory of Molecular Pharmacology, Faculty of Health Science, University of BrasiliaBrasilia, Brazil.
Alexandre G MartiniLaboratory of Molecular Pharmacology, Faculty of Health Science, University of BrasiliaBrasilia, Brazil.
Gabriela T PazzineLaboratory of Molecular Pharmacology, Faculty of Health Science, University of BrasiliaBrasilia, Brazil.
Maria de F BorinLaboratory of Molecular Pharmacology, Faculty of Health Science, University of BrasiliaBrasilia, Brazil.
Angelica A AmatoLaboratory of Molecular Pharmacology, Faculty of Health Science, University of BrasiliaBrasilia, Brazil.
Francisco de A R NevesLaboratory of Molecular Pharmacology, Faculty of Health Science, University of BrasiliaBrasilia, Brazil.
Universidade de Brasília · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Organotins are a group of chemical compounds that have a tin atom covalently bound to one or more organic groups. The best-studied organotin is tributyltin chloride, which is an environmental pollutant and an endocrine disruptor. Tributyltin chloride has been shown to bind to PPARγ/RXRα and induces adipogenesis in different mammalian cells. However, there are few studies with other organotin compounds, such as dibutyltins. The aim of this study was to investigate the effect of dibutyltins diacetate, dichloride, dilaurate, and maleate on the transcriptional activity of the nuclear PPARγ and RXRα receptors, and on adipogenesis and inflammation. Analogous to tributyltin chloride, in reporter gene assay using HeLa cells, we observed that dibutyltins diacetate, dichloride, dilaurate, and maleate are partial agonists of PPARγ. Unlike tributyltin chloride, which is a full agonist of RXRα, dibutyltins dichloride and dilaurate are partial RXRα agonists. Additionally, the introduction of the C285S mutation, which disrupts tributyltin chloride binding to PPARγ, abrogated the dibutyltin agonistic activity. In 3T3-L1 preadipocytes, all dibutyltin induced adipogenesis, although the effect was less pronounced than that of rosiglitazone and tributyltin chloride. This adipogenic effect was confirmed by the expression of adipogenic markers Fabp4, Adipoq, and Glut4. Exposure of 3T3-L1 cells with dibutyltin in the presence of T0070907, a specific PPARγ antagonist, reduced fat accumulation, suggesting that adipogenic effect occurs through PPARγ. Furthermore, dibutyltins dichloride, dilaurate, and maleate inhibited the expression of proinflammatory genes in 3T3-L1 cells, such as Vcam1, Dcn, Fn1, S100a8, and Lgals9. Additionally, in RAW 264.7 macrophages, tributyltin chloride and dibutyltin dilaurate reduced LPS-stimulated TNFα expression. Our findings indicate that dibutyltins diacetate, dichloride, dilaurate, and maleate are PPARγ partial agonists and that dibutyltins dichloride and dilaurate are also partial RXRα agonists. Furthermore, dibutyltins induce adipogenesis in a PPARγ-dependent manner and repress inflammatory genes in 3T3-L1 and RAW 264.7 cells. Although dibutyltins display some partial PPARγ/RXRα agonistic effects, the translation of cell-based results assays into in vivo effects on inflammation and insulin resistance is not entirely known. Nevertheless, further studies are necessary to address their effects in different periods of life and to elucidate the actions of organostanic compounds in whole-body context.

Indexed as

adipogenesisdibutyltinperoxisome proliferator activated receptor gammaproinflammatory genestributyltin

Identifiers

PMID28824431
PMCPMC5539189
OpenAlexW2741630457

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.